首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1638774

肠内餵食配方奶粉市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

Enteral Feeding Formulas Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年11月05日 | 出版商:

Global Market Insights Inc. | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

全球肠内餵食配方奶粉市场将于2023 年达到70 亿美元，预计2024 年至2032 年将以7.1% 的复合年增长率增长。口服食物的人）设计的液体营养产品：吞嚥困难、胃肠道疾病或神经系统损伤。这些配方奶粉通常透过饲管施用，将营养物质直接输送到胃或小肠。

市面上有多种配方，如标准配方、特定疾病配方、元素配方、半元素配方等。标准配方奶粉细分市场占据最大的市场份额，到 2023 年贡献 36 亿美元。这些完整的营养配方易于取得且价格实惠，适用于医院和家庭护理环境，预计将在未来几年推动该领域的显着成长。

该市场也按年龄组别划分，2023年成人细分市场处于领先地位，占市场总收入的82.2%。这一趋势主要是由越来越多的老年人推动的，由于与老化相关的各种健康挑战，他们经常需要肠内餵食。随着医疗保健系统适应老龄化人口的营养需求，肠内营养的需求预计将继续增长，进一步推动这一领域的发展。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	70 亿美元
预测值	129 亿美元
复合年增长率	7.1%

依最终用途划分，肠内餵食配方奶粉市场分为医院、长期照护机构、家庭照护机构和疗养院。到 2023 年，医院领域的价值将达到 32 亿美元，在市场成长中发挥关键作用。人们越来越认识到适当营养对患者復原的重要性，这促使医院采用肠内餵食解决方案。众所周知，肠内营养可以加速癒合、减少併发症并缩短恢復时间，因此在医院的使用越来越多。

在美国，2023年肠内餵食配方奶粉市值为28亿美元，预计预测期内复合年增长率为7.2%。美国市场的特点是产品配方不断创新，包括无乳糖、无麸质和低残留的选择，满足广泛的患者需求。美国人口老化是推动需求的一个主要因素，因为老年人经常面临无法口服饮食的状况。这种人口趋势预计将维持肠内餵食配方奶粉市场的长期成长。

产业生态系统分析
产业影响力
- 成长动力
  - 老年人口增加和慢性病盛行率
  - 新生儿和早产儿肠内餵食的需求不断增长
  - 家庭护理环境中肠内餵食的需求不断增加
  - 消费特定疾病配方奶粉的趋势正在转变
- 产业陷阱与挑战
  - 肠内餵食相关的高成本
  - 併发症的风险
成长潜力分析
监管环境
技术景观
- 核心技术
- 邻近技术
定价分析
- 按地区
- 副产品
消费者行为分析
未来市场趋势
专利分析
管道分析
临床试验情况
差距分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
标准配方
疾病特定配方
元素公式
半基本公式
其他公式

第 6 章：市场估计与预测：按阶段，2021 - 2032

主要趋势
成年人
儿科

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
肿瘤学
胃肠道疾病
神经系统疾病
糖尿病
重症监护
其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
长期照护设施
家庭护理设置
疗养院

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋

第 10 章：公司简介

Abbott Laboratories
B. Braun Melsungen AG
Baxter International
Danone SA
Fresenius Kabi
Functional Formularies
Hormel Health Labs
Kate Farms
Medtrition
Meiji Holdings
Nestle
NutriMedical
Real Food Blends
Vegenat Healthcare
Victus

简介目录

Product Code: 12131

The Global Enteral Feeding Formulas Market reached USD 7 billion in 2023 and is expected to grow at a CAGR of 7.1% from 2024 to 2032. Enteral feeding formulas are specialized liquid nutrition products designed for individuals who cannot consume food orally due to medical conditions such as swallowing difficulties, gastrointestinal disorders, or neurological impairments. These formulas are typically administered via a feeding tube that delivers nutrients directly to the stomach or small intestine.

The market includes a variety of formulas, such as standard formulas, disease-specific formulas, elemental formulas, semi-elemental formulas, and others. The standard formulas segment held the largest market share, contributing USD 3.6 billion in 2023. Their broad usage across diverse patient populations, along with their cost-effectiveness, makes them a preferred choice. The easy availability and affordability of these complete nutritional formulas, suitable for both hospital and home care settings, are expected to drive significant growth in this segment over the coming years.

The market is also divided by age group, with the adult segment leading in 2023, accounting for 82.2% of the total market revenue. This trend is primarily driven by the increasing number of elderly individuals who often require enteral feeding due to various health challenges associated with aging. As healthcare systems adapt to meet the nutritional needs of an aging population, the demand for enteral nutrition is expected to continue growing, further boosting this segment.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$7 Billion
Forecast Value	$12.9 Billion
CAGR	7.1%

By end use, the enteral feeding formula market is segmented into hospitals, long-term care facilities, home care settings, and nursing homes. The hospital segment, valued at USD 3.2 billion in 2023, plays a key role in the market's growth. Increasing awareness about the importance of proper nutrition in patient recovery is driving hospitals to adopt enteral feeding solutions. Enteral nutrition is known to speed up healing, reduce complications, and shorten recovery times, leading to its growing use in hospitals.

In the U.S., the enteral feeding formula market was valued at USD 2.8 billion in 2023, with an anticipated growth rate of 7.2% CAGR during the forecast period. The U.S. market is characterized by continuous innovations in product formulations, including lactose-free, gluten-free, and low-residue options, catering to a wide range of patient needs. The aging population in the U.S. is a major factor driving demand, as older adults often struggle with conditions that prevent them from eating orally. This demographic trend is expected to sustain long-term growth in the enteral feeding formula market.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising geriatric population and chronic disease prevalence
  - 3.2.1.2 Growing demand for neonatal and preterm enteral feeding
  - 3.2.1.3 Increasing demand for enteral feeding in home care settings
  - 3.2.1.4 Shifting trend toward consumption of disease-specific formulas
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High costs associated with enteral feeding
  - 3.2.2.2 Risk of complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis
- 3.6.1 By region
- 3.6.2 By product
3.7 Consumer behavior analysis
3.8 Future market trends
3.9 Patent analysis
3.10 Pipeline analysis
3.11 Clinical trial landscape
3.12 Gap analysis
3.13 Porter's analysis
3.14 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Standard formulas
5.3 Disease specific formulas
5.4 Elemental formulas
5.5 Semi-elemental formulas
5.6 Other formulas

Chapter 6 Market Estimates and Forecast, By Stage, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Adults
6.3 Pediatric

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Oncology
7.3 Gastrointestinal diseases
7.4 Neurological disorders
7.5 Diabetes
7.6 Critical care
7.7 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Long term care facilities
8.4 Home care settings
8.5 Nursing homes

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE